{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T14:33:31Z","timestamp":1794148411242,"version":"4.8.0"},"reference-count":56,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2022,5,1]]},"DOI":"10.1001\/jamadermatol.2022.0160","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T16:04:34Z","timestamp":1648656274000},"page":"495","source":"Crossref","is-referenced-by-count":1412,"title":["Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040"],"prefix":"10.1001","volume":"158","author":[{"given":"Melina","family":"Arnold","sequence":"first","affiliation":[{"name":"Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deependra","family":"Singh","sequence":"additional","affiliation":[{"name":"Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Laversanne","sequence":"additional","affiliation":[{"name":"Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Vignat","sequence":"additional","affiliation":[{"name":"Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Vaccarella","sequence":"additional","affiliation":[{"name":"Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Meheus","sequence":"additional","affiliation":[{"name":"Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Cust","sequence":"additional","affiliation":[{"name":"The Daffodil Centre, The University of Sydney with Cancer Council New South Wales, Sydney, Australia"},{"name":"Melanoma Institute Australia, The University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"de Vries","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Biostatistics, Pontificia Universidad Javeriana, Bogota, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Whiteman","sequence":"additional","affiliation":[{"name":"Cancer Control Group, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddie","family":"Bray","sequence":"additional","affiliation":[{"name":"Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"doi220006r1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ijc.27616","article-title":"International trends in the incidence of malignant melanoma 1953-2008\u2014are recent generations at higher or lower risk?","volume":"132","author":"Erdmann","year":"2013","journal-title":"Int J Cancer"},{"issue":"9","key":"doi220006r2","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/jdv.12236","article-title":"Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015.","volume":"28","author":"Arnold","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"doi220006r3","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S1470-2045(09)70213-X","article-title":"A review of human carcinogens\u2014part D: radiation.","volume":"10","author":"El Ghissassi","year":"2009","journal-title":"Lancet Oncol"},{"issue":"6","key":"doi220006r5","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/ijc.v143.6","article-title":"Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012.","volume":"143","author":"Arnold","year":"2018","journal-title":"Int J Cancer"},{"issue":"12","key":"doi220006r6","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S1470-2045(17)30677-0","article-title":"Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study.","volume":"18","author":"Fidler","year":"2017","journal-title":"Lancet Oncol"},{"issue":"6","key":"doi220006r7","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jid.2016.01.035","article-title":"The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031.","volume":"136","author":"Whiteman","year":"2016","journal-title":"J Invest Dermatol"},{"key":"doi220006r8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejca.2021.04.029","article-title":"Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943-2036.","volume":"152","author":"Garbe","year":"2021","journal-title":"Eur J Cancer"},{"issue":"1","key":"doi220006r9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jamadermatol.2019.3353","article-title":"Age-specific incidence of melanoma in the United States.","volume":"156","author":"Paulson","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"5","key":"doi220006r10","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/ijc.v147.5","article-title":"Long-term deaths from melanoma according to tumor thickness at diagnosis.","volume":"147","author":"Baade","year":"2020","journal-title":"Int J Cancer"},{"key":"doi220006r11","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.v149.4","article-title":"Cancer statistics for the year 2020: an overview.","author":"Ferlay","year":"2021","journal-title":"Int J Cancer"},{"issue":"3","key":"doi220006r12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.v71.3","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"doi220006r15","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.v144.8","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"issue":"5","key":"doi220006r16","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"issue":"12","key":"doi220006r17","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.v127:12","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"issue":"120","key":"doi220006r20","first-page":"862","article-title":"Cancer incidence in five continents. cumulative rate and cumulative risk.","author":"Day","year":"1992","journal-title":"IARC Sci Publ"},{"issue":"8","key":"doi220006r22","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.3390\/ijerph18084165","article-title":"Trends in incidence and mortality of skin melanoma in Lithuania 1991-2015.","volume":"18","author":"Dulskas","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"doi220006r23","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/1753-6405.12470","article-title":"Cancers in Australia attributable to exposure to solar ultraviolet radiation and prevented by regular sunscreen use.","volume":"39","author":"Olsen","year":"2015","journal-title":"Aust N Z J Public Health"},{"issue":"6","key":"doi220006r24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/00008390-199311000-00002","article-title":"How much melanoma is caused by sun exposure?","volume":"3","author":"Armstrong","year":"1993","journal-title":"Melanoma Res"},{"issue":"1","key":"doi220006r25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2217\/mmt.14.6","article-title":"Towards skin cancer prevention and early detection: evolution of skin cancer awareness campaigns in Australia.","volume":"1","author":"Iannacone","year":"2014","journal-title":"Melanoma Manag"},{"key":"doi220006r26","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1016\/j.canep.2016.02.005","article-title":"The burden of cutaneous melanoma and status of preventive measures in Central and South America.","volume":"44","author":"de Vries","year":"2016","journal-title":"Cancer Epidemiol"},{"issue":"8","key":"doi220006r27","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1158\/1055-9965.EPI-05-0097","article-title":"Etiologic and other factors predicting nevus-associated cutaneous malignant melanoma.","volume":"14","author":"Purdue","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"doi220006r28","author":"Gandini","year":"2005"},{"issue":"5","key":"doi220006r29","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41588-020-0611-8","article-title":"Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility.","volume":"52","author":"Landi","year":"2020","journal-title":"Nat Genet"},{"issue":"20","key":"doi220006r30","doi-asserted-by":"publisher","first-page":"9818","DOI":"10.1158\/0008-5472.CAN-06-0494","article-title":"High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.","volume":"66","author":"Goldstein","year":"2006","journal-title":"Cancer Res"},{"issue":"1","key":"doi220006r31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/ng0196-97","article-title":"Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma.","volume":"12","author":"Zuo","year":"1996","journal-title":"Nat Genet"},{"issue":"3","key":"doi220006r32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ng1195-328","article-title":"Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans.","volume":"11","author":"Valverde","year":"1995","journal-title":"Nat Genet"},{"issue":"5","key":"doi220006r33","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/jamadermatol.2020.0470","article-title":"Evaluation of sex-specific incidence of melanoma.","volume":"156","author":"Olsen","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"7","key":"doi220006r34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071819","article-title":"Sex and gender disparities in melanoma.","volume":"12","author":"Bellenghi","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"3","key":"doi220006r35","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1016\/S2468-2667(18)30267-6","article-title":"Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry.","volume":"4","author":"Sung","year":"2019","journal-title":"Lancet Public Health"},{"issue":"11","key":"doi220006r36","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1038\/sj.bjc.6603801","article-title":"Melanoma incidence and mortality in Scotland 1979-2003.","volume":"96","author":"MacKie","year":"2007","journal-title":"Br J Cancer"},{"key":"doi220006r37","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.4512","article-title":"Analysis of trends in US melanoma incidence and mortality.","author":"Glazer","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"9","key":"doi220006r38","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/cncr.v101:9","article-title":"Invasive cutaneous malignant melanoma in Sweden, 1990-1999: a prospective, population-based study of survival and prognostic factors.","volume":"101","author":"Lindholm","year":"2004","journal-title":"Cancer"},{"issue":"16","key":"doi220006r39","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1016\/j.ejca.2004.06.003","article-title":"Cutaneous malignant melanoma in Europe.","volume":"40","author":"de Vries","year":"2004","journal-title":"Eur J Cancer"},{"issue":"10125","key":"doi220006r40","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37?513?025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"doi220006r41","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejca.2017.12.024","article-title":"Trends in incidence of thick, thin and in situ melanoma in Europe.","volume":"92","author":"Sacchetto","year":"2018","journal-title":"Eur J Cancer"},{"issue":"5","key":"doi220006r43","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2105\/AJPH.2020.305567","article-title":"New systematic therapies and trends in cutaneous melanoma deaths among US whites, 1986-2016.","volume":"110","author":"Berk-Krauss","year":"2020","journal-title":"Am J Public Health"},{"issue":"9","key":"doi220006r44","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1080\/14656566.2019.1601700","article-title":"Current and emerging systemic therapies for cutaneous metastatic melanoma.","volume":"20","author":"Mason","year":"2019","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"doi220006r45","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/jid.2014.452","article-title":"More people die from thin melanomas (=1?mm) than from thick melanomas (>4?mm) in Queensland, Australia.","volume":"135","author":"Whiteman","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"1","key":"doi220006r46","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/ijc.25996","article-title":"Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990-2006.","volume":"130","author":"Baade","year":"2012","journal-title":"Int J Cancer"},{"issue":"18","key":"doi220006r47","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1016\/j.ejca.2015.09.008","article-title":"Increasing time trends of thin melanomas in The Netherlands: what are the explanations of recent accelerations?","volume":"51","author":"van der Leest","year":"2015","journal-title":"Eur J Cancer"},{"key":"doi220006r48","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ypmed.2016.08.032","article-title":"Melanoma burden and recent trends among non-Hispanic whites aged 15-49 years, United States.","volume":"91","author":"Watson","year":"2016","journal-title":"Prev Med"},{"issue":"1","key":"doi220006r49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016.","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"doi220006r50","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1056\/NEJMsb2019760","article-title":"The rapid rise in cutaneous melanoma diagnoses.","volume":"384","author":"Welch","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"doi220006r51","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/bjc.2012.22","article-title":"Skin cancer screening participation and impact on melanoma incidence in Germany\u2014an observational study on incidence trends in regions with and without population-based screening.","volume":"106","author":"Waldmann","year":"2012","journal-title":"Br J Cancer"},{"issue":"1","key":"doi220006r52","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jaad.2016.07.045","article-title":"Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: a systematic review.","volume":"76","author":"Brunssen","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"doi220006r53","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/CMR.0000000000000489","article-title":"Stage-specific incidence trends of melanoma in an English region, 1996-2015: longitudinal analyses of population-based data.","volume":"30","author":"Herbert","year":"2020","journal-title":"Melanoma Res"},{"issue":"2","key":"doi220006r54","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1023\/A:1014344519276","article-title":"Practical implications of imposing a new world standard population.","volume":"13","author":"Bray","year":"2002","journal-title":"Cancer Causes Control"},{"issue":"1","key":"doi220006r55","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrc1781","article-title":"Predicting the future burden of cancer.","volume":"6","author":"Bray","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"doi220006r56","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3389\/fimmu.2019.00453","article-title":"Combining immune checkpoint inhibitors: established and emerging targets and strategies to improve outcomes in melanoma.","volume":"10","author":"Khair","year":"2019","journal-title":"Front Immunol"},{"key":"doi220006r4","year":"2012"},{"key":"doi220006r18","volume-title":"Cancer Mortality for Selected Sites in 24 Countries (1950-1957)","author":"Segi","year":"1960","edition":"2nd ed"},{"key":"doi220006r19","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-85849-9","volume-title":"Cancer Incidence in Five Continents: A Technical Report","author":"Doll","year":"1966"},{"key":"doi220006r21","doi-asserted-by":"crossref","DOI":"10.18356\/9789210055161","volume-title":"Human Development Report 2020","author":"United Nations Development Programme","year":"2020"},{"key":"doi220006r42","volume-title":"Cancer Survival in Africa, Asia, the Caribbean and Central America","year":"2011"},{"key":"doi220006r13","unstructured":"International Agency for Research on Cancer: Global Cancer Observatory. Cancer today. Published 2021. Accessed April 28, 2021. https:\/\/gco.iarc.fr\/today\/home"},{"key":"doi220006r14","unstructured":"United Nations Statistics Division. Standard country or area codes for statistical use (M49): aggregated. Published 2021. Accessed April 28, 2021."}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2790344\/jamadermatology_arnold_2022_oi_220006_1652203168.45037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T11:09:57Z","timestamp":1652872197000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2790344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,1]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2022.0160","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,1]]}}}